Calithera Biosciences

CALA · OTC

$0.00+$0.0001 (−100.00%)TodayMarket closed · Oct 19, 1:44 PM ET

Prev close -$0.0001

About CALA

Calithera Biosciences, Inc. is a clinical stage precision oncology biopharmaceutical company, which engages in developing targeted therapies to redefine treatment for biomarker-specific patient populations. The firm is winding up its operations. The firm is seeking to sell all of its clinical assets and programs. The firm has not generated any revenue.

Employees: 8
Headquarters: South San Francisco, California
Listed: Oct 2, 2014
Sector: Health Care
Industry: Biotechnology
Website: calithera.com

Leadership

Calithera Biosciences executives
Name	Title	Since	Age
Susan Molineaux	—	2010	71
Stephanie Wong	—	—	51
Emil Kuriakose	—	—	45
Deepika Pakianathan	—	—	60
Keith Orford	—	2015	51
Sunil Agarwal	—	—	53
Scott Garland	—	—	54
Suzy Jones	—	—	57
Blake Wise	—	—	52
H. Ward Wolff	—	—	75

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Calithera Biosciences suppliers and customers
Company	Relationship	Country	Correlation
Antengene Corp Rg	Supplier and customer	CN	0.82
Incyte INCY	Supplier and customer	US	0.08
Pfizer PFE	Supplier and customer	US	-0.74
Mars, Inc.	Supplier and customer	US	—

Similar companies

Companies in the same industry as Calithera Biosciences

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.